Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693654 · ClinicalTrials.gov registry record · Phase 4
Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
A Phase 4 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT00693654 is a Phase 4 study that has completed, run by Wake Forest University. The registered enrollment target is 28 participants.
The verdict
NCT00693654, a Phase 4 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the efficacy of SARNA Sensitive Lotion in the treatment of uremic pruritus in adult hemodialysis patients in a double-blind Controlled comparative trial.
Interventions
- DRUG Cetaphil
- DRUG Sarna
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00693654
The ClinicalTrials.gov registry entry for NCT00693654 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cetaphil is the first listed.
NCT00693654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00693654 about?
NCT00693654 is a clinical study titled "Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients". The purpose of this research study is to evaluate the efficacy of SARNA Sensitive Lotion in the treatment of uremic pruritus in adult hemodialysis patients in a double-blind Controlled comparative trial.
What is the current status of trial NCT00693654?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2006-11. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00693654?
The interventions under investigation include: Cetaphil (DRUG), Sarna (DRUG).
Who is sponsoring clinical trial NCT00693654?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.